Back to Journals » Pediatric Health, Medicine and Therapeutics » Call For Papers

Pediatric Health, Medicine and Therapeutics


The following Article Collection/ Thematic Series is currently open for submissions:

COVID-19 and pediatric care

Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “COVID-19 and pediatric care", edited by Editor-in-Chief Professor Laurens Holmes in Pediatric Health, Medicine and Therapeutics.

Upon submission, please use the promo code KQXVK for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series "COVID-19 and pediatric care". The deadline for manuscripts is the 1st of September 2022.

For any enquiries, please email Dr Gail Smith at [email protected]

About the Thematic Series

While COVID-19 has affected all age groups in various ways, the youngest in our society may have struggled to achieve the early childhood that all parents hope for their children. This includes children struggling with chronic illness and conditions early in their life, as COVID-19 impacts all facets of the ideal life for children. The impact of COVID-19 on children’s physical health can range from being unable to visit the doctor for a typical case of childhood chickenpox, to restrictions on receiving life-saving chemotherapy due to resources being shifted.

Lockdowns impacted the ability to seek pediatric care, from dentistry, general practice to psychiatry, alongside closing schools. The cognitive and social growth that school fosters may have been slowed by such closures, along with confining children to their homes, in situations where they may be unable to play with other children or have family members juggling occupational and childcare requirements. Developmental milestones may have suffered as a result, and the idea of a ‘thriving’ child grown further out of sight.

How did COVID-19 affect children, inside and out? Did telehealth really do enough when providing care for children? How do we dissect the impact of post-lockdown reintegration and COVID-19 infections in schools? These questions, and more, will have a role in this Thematic Series in assembling the wider picture of COVID-19 and pediatric care.

SARS-CoV2, the causative pathogen in COVID-19, requires mutualistic and symbiotic data, especially given immune responsiveness in children. To achieve this, the fields of medicine and public health require dynamic data in preventive measures, treatment, prognosis and mortality. Through these data, understanding on pediatric infections of COVID-19 and its relationship to comorbidities, complications and long COVID can be sought. Moreover, data can highlight the adverse impact on healthcare providers that marginalizes pediatric care. This Thematic Series in Pediatric Health, Medicine and Therapeutics invites researchers, clinicians and public health experts in children's health to submit their findings for publication. Specifically, the Editor-in-Chief welcomes publications on the topics of immunology and infectious diseases, with expert oversight ensuring that invited authors benefit from the critical review of their findings. To learn more about the Editor-in-Chief’s work in this area, please see the paper "Black-white risk differentials in COVID-19 (SARS-CoV2) transmission, mortality and case fatality in the United States: translational epidemiologic perspective and challenges" led by Professor Laurens Holmes Jr.

Holmes Jr L, Enwere M, Williams J et al. Black–white risk differentials in COVID-19 (SARS-CoV2) transmission, mortality and case fatality in the United States: translational epidemiologic perspective and challenges. Int J Environ Res Public Health. 2020;17(12):4322.

The journal is seeking original submissions and review articles on the following topics related to COVID-19 and how children may have been affected:

• Impact of COVID-19 on children with immunity-compromising conditions (e.g., diabetes, cancer, primary immunodeficiency)
• Children with conditions requiring specialist care (e.g., pediatric cancers, genetic disorders)
• Reaching developmental milestones in speech and motor abilities, failure to thrive
• Effects of COVID-19 on emotional wellbeing, accessibility of pediatric psychiatry
• Oral health in children, effect on pediatric dentistry
• Provision of general and emergency healthcare during COVID-19
• Telehealth for pediatric appointments

Submit your manuscript
https://www.dovepress.com/submit_step_1.php

View all papers in this thematic series


Call For Papers

To see where Pediatric Health, Medicine and Therapeutics is indexed online view the Journal Metrics 

What is the advantage to you of publishing in Pediatric Health, Medicine and Therapeutics?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  •  The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Pediatric Health, Medicine and Therapeutics has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.

PubMed Central
Pediatric Health, Medicine and Therapeutics is indexed on PubMed Central (title abbreviation: Pediatric Health Med Ther). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Professor Laurens Holmes, Jr
Editor-in-Chief
Pediatric Health, Medicine and Therapeutics

Email: Editor-in-Chief

Related journals you may also be interested in: